Endocannabinoid signalling in the blood of patients with schizophrenia

AIM: To test the hypothesis that schizophrenia might be associated with alterations of the endogenous cannabinoid system in human blood. RESULTS: Blood from 20 healthy volunteers and 12 patients with schizophrenia, 5 of which both before and after a successful antipsychotic treatment, was analysed f...

Descripción completa

Detalles Bibliográficos
Autores principales: De Marchi, Nicola, De Petrocellis, Luciano, Orlando, Pierangelo, Daniele, Fabiana, Fezza, Filomena, Di Marzo, Vincenzo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194767/
https://www.ncbi.nlm.nih.gov/pubmed/12969514
http://dx.doi.org/10.1186/1476-511X-2-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194767/
https://www.ncbi.nlm.nih.gov/pubmed/12969514
http://dx.doi.org/10.1186/1476-511X-2-5

Ejemplares similares